Developer docs
API playgroundTry for free, no card

Search company profiles

National Institute of General Medical Science

Full company profile

uuid0006kxb

Namestring
National Institute of General Medical Science
Legal namestring
National Institute of General Medical Sciences
Websiteurl
nigms.nih.gov
Company typeenum
Public
Founded yearint
1962
Descriptiontext

The National Institute of General Medical Sciences (NIGMS) is a U.S. federal research funding institute established by Congress in 1962 and operating as a component of the National Institutes of Health (NIH), within the Department of Health and Human Services. Headquartered at 45 Center Drive, Bethesda, Maryland, NIGMS supports basic biomedical research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. The institute is organized around four core research areas: Biophysics, Biomedical Technology, and Computational Biosciences; Genetics and Molecular, Cellular, and Developmental Biology; Pharmacology, Physiology, and Biological Chemistry; and Research Capacity Building, plus a Training and Workforce Development function.

NIGMS does not develop proprietary technology products. Its "offerings" are a portfolio of grant mechanisms and research resources, including Research Project Grants (R01), the Maximizing Investigators' Research Award (MIRA), the Institutional Development Award (IDeA), Native American Research Centers for Health (NARCH), Support for Research Excellence (SuRE), the Science Education Partnership Award (SEPA), MOSAIC, the Advancing Research Careers (ARC) program, the Instrumentation Grant Program for Resource-Limited Institutions (RLI-S10), National and Regional Resources (NRRs), Biomedical Technology Optimization and Dissemination (BTOD) Centers, and the Mature Synchrotron Resources (MSR) program. Distribution is conducted via NIH eRA Commons, the NIH Guide for Grants and Contracts, and grants.gov under formal peer-reviewed application processes.

NIGMS is funded through annual congressional appropriations as part of the NIH federal budget, with a stated annual budget of approximately $3.2 billion. It is staffed by approximately 220 employees. Its end customers are U.S. principal investigators, research universities, resource-limited institutions, HBCUs, tribal-serving institutions, and small businesses (via SBIR/STTR). NIGMS does not sell goods or services and has no equity, ownership structure, or investor base.

Short descriptiontext

The National Institute of General Medical Sciences is a U.S. federal research institute within NIH that funds basic biomedical research, research training, and research capacity building at U.S. universities, resource-limited institutions, and small businesses through competitive grant mechanisms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBethesda, United States
HQ citystring
Bethesda
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research funding, research training grants, basic medical science, research capacity building, scientific workforce development
Industry3 codes
1Health Research Funding Agencies (Public/Quasi-Public)
CodeHLAJALABPrimaryYes
2Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryNo
3Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryNo
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Colleges, Universities, and Professional Schools61131
SIC code2 codes
  • Services-Educational Services8200
  • Services-Commercial Physical & Biological Research8731
Product category
Government Research Funding
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Federal Government Appropriations
TypeLicensing Royalties
Description

NIGMS receives annual appropriations from the U.S. federal government through the National Institutes of Health budget. The institute uses these funds to support research grants, training programs, and capacity building initiatives across American universities and research institutions.

nigms.nih.gov
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Others, Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The National Institute of General Medical Sciences (NIGMS) is a U.S. federal research institute within the National Institutes of Health (NIH) that distributes federal appropriations as competitive research grants to support basic biomedical research. It funds principal investigators, research institutions, training programs, and capacity-building initiatives across American universities and research institutions through grant mechanisms such as R01, MIRA, IDeA, NARCH, SuRE, and SEPA.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • NIGMS grantees Victor Ambros and Gary Ruvkun received 2024 Nobel Prize in Physiology or Medicine for microRNA discovery
+1 more record
Product overview1 text field

The National Institute of General Medical Sciences (NIGMS) is a federal research institute within NIH that supports basic biomedical research through grant funding mechanisms, not commercial products. NIGMS offers a portfolio of grant programs including: Research Project Grants (R01), Maximizing Investigators' Research Award (MIRA), and specialized programs like IDeA, NARCH, SuRE, and SEPA for capacity building and education. Training programs include predoctoral T32 training, MOSAIC, and ARC for workforce development. Research resources include National and Regional Resources (NRRs), BTOD Centers, and MSR facilities. The institute's offerings are organized around four core areas: Biophysics/Biomedical Technology/Computational Biosciences; Genetics/Molecular/Cellular/Developmental Biology; Pharmacology/Physiology/Biological Chemistry; and Research Capacity Building.

Product and service1 record
1Research Project Grants (R01)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Fellow NIH institute with comparable statutory authority to distribute federal biomedical research grants and operate intramural programs; the closest analogue in mission structure and scale, though disease-focused on cancer rather than basic science.

TypeDirect peer
Description

One of the largest NIH institutes, sharing NIGMS's federal-grantmaking model, peer review through CSR, and appropriations-funded budget; cited in NIGMS's FOIA correspondence, evidencing cross-institute operational ties.

TypeDirect peer
Description

NIH institute funding biomedical research with a comparable grants/contracts apparatus; noted as a prior employer of NIGMS's GMCDB director, illustrating the close inter-institute leadership circulation across NIH.

TypeDirect peer
Description

NIH institute with parallel grant programs (R01, P01, training) and shared administrative infrastructure; comparable in funding mechanisms, peer-review pathways, and congressional appropriations dynamics.

TypeDirect peer
Description

NIH institute funding biomedical and behavioral research with overlapping training and workforce development programs; structurally and operationally comparable to NIGMS as a federal grantmaking body.

6National Center for Advancing Translational Sciences (NCATS)
TypeDirect peer
Description

NIH center focused on translational science; shares NIGMS's grant and training mechanisms and was a prior employer of an NIGMS division director, evidencing interagency personnel flow and parallel program design.

TypeBroad incumbent
Description

Largest federal basic-research funder; overlaps with NIGMS on investigator-initiated biomedical and biological sciences research, but at broader scientific scope and without NIH's disease-specific mandate.

TypeEmerging player
Description

Large private biomedical research funder supporting investigator-driven basic science at host institutions; runs a comparable scientist-support model rather than open R01-style competitive grants, but competes for talent and prestige in the same research ecosystem.

TypeEmerging player
Description

UK-headquartered global charitable foundation that funds basic biomedical research and research training; analogous mission to NIGMS but private/charity-funded and internationally scoped, often co-funding investigators alongside NIH.

TypeOthers
Description

Federal basic-research funder operating national user facilities (e.g., synchrotron light sources) that overlap with NIGMS's Mature Synchrotron Resources program; comparable as a federally funded science agency, though focused on physical rather than life sciences.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment48 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Institute of General Medical Science

Government Research Fundingnigms.nih.gov

The National Institute of General Medical Sciences is a U.S. federal research institute within NIH that funds basic biomedical research, research training, and research capacity building at U.S. universities, resource-limited institutions, and small businesses through competitive grant mechanisms.

What National Institute of General Medical Science does

The National Institute of General Medical Sciences (NIGMS) is a U.S. federal research funding institute established by Congress in 1962 and operating as a component of the National Institutes of Health (NIH), within the Department of Health and Human Services. Headquartered at 45 Center Drive, Bethesda, Maryland, NIGMS supports basic biomedical research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. The institute is organized around four core research areas: Biophysics, Biomedical Technology, and Computational Biosciences; Genetics and Molecular, Cellular, and Developmental Biology; Pharmacology, Physiology, and Biological Chemistry; and Research Capacity Building, plus a Training and Workforce Development function.

NIGMS does not develop proprietary technology products. Its "offerings" are a portfolio of grant mechanisms and research resources, including Research Project Grants (R01), the Maximizing Investigators' Research Award (MIRA), the Institutional Development Award (IDeA), Native American Research Centers for Health (NARCH), Support for Research Excellence (SuRE), the Science Education Partnership Award (SEPA), MOSAIC, the Advancing Research Careers (ARC) program, the Instrumentation Grant Program for Resource-Limited Institutions (RLI-S10), National and Regional Resources (NRRs), Biomedical Technology Optimization and Dissemination (BTOD) Centers, and the Mature Synchrotron Resources (MSR) program. Distribution is conducted via NIH eRA Commons, the NIH Guide for Grants and Contracts, and grants.gov under formal peer-reviewed application processes.

NIGMS is funded through annual congressional appropriations as part of the NIH federal budget, with a stated annual budget of approximately $3.2 billion. It is staffed by approximately 220 employees. Its end customers are U.S. principal investigators, research universities, resource-limited institutions, HBCUs, tribal-serving institutions, and small businesses (via SBIR/STTR). NIGMS does not sell goods or services and has no equity, ownership structure, or investor base.

National Institute of General Medical Science firmographics

Firmographics
Name
National Institute of General Medical Science
Legal name
National Institute of General Medical Sciences
Website
https://nigms.nih.gov
Company type
Public
Founded year
1962
Operating status
Operating
Headcount range
101–250 employees
Short description
The National Institute of General Medical Sciences is a U.S. federal research institute within NIH that funds basic biomedical research, research training, and research capacity building at U.S. universities, resource-limited institutions, and small businesses through competitive grant mechanisms.
Ownership category
akta.pro rank

National Institute of General Medical Science industry classification

Industry
Product category
Government Research Funding
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Colleges, Universities, and Professional Schools (61131)
SIC
Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)
akta.pro secondary industries
Research & Science Grantmaking Foundations (BPAGAKAI), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

  • Biomedical research funding
  • Research training grants
  • Basic medical science
  • Research capacity building
  • Scientific workforce development

Where National Institute of General Medical Science is headquartered

Location

Headquarters

HQ city
Bethesda
HQ country
United States
HQ region
North America

Offices1 record

Markets served

National Institute of General Medical Science business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others, Personnel, Operations

Revenue model

  1. Federal Government Appropriations: NIGMS receives annual appropriations from the U.S. federal government through the National Institutes of Health budget. The institute uses these funds to support research grants, training programs, and capacity building initiatives across American universities and research institutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

National Institute of General Medical Science product offering

Product offering

Core offering

The National Institute of General Medical Sciences (NIGMS) is a U.S. federal research institute within the National Institutes of Health (NIH) that distributes federal appropriations as competitive research grants to support basic biomedical research. It funds principal investigators, research institutions, training programs, and capacity-building initiatives across American universities and research institutions through grant mechanisms such as R01, MIRA, IDeA, NARCH, SuRE, and SEPA.

Product overview

The National Institute of General Medical Sciences (NIGMS) is a federal research institute within NIH that supports basic biomedical research through grant funding mechanisms, not commercial products. NIGMS offers a portfolio of grant programs including: Research Project Grants (R01), Maximizing Investigators' Research Award (MIRA), and specialized programs like IDeA, NARCH, SuRE, and SEPA for capacity building and education. Training programs include predoctoral T32 training, MOSAIC, and ARC for workforce development. Research resources include National and Regional Resources (NRRs), BTOD Centers, and MSR facilities. The institute's offerings are organized around four core areas: Biophysics/Biomedical Technology/Computational Biosciences; Genetics/Molecular/Cellular/Developmental Biology; Pharmacology/Physiology/Biological Chemistry; and Research Capacity Building.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research Project Grants (R01)

Quantifiable outcome

  • NIGMS grantees Victor Ambros and Gary Ruvkun received 2024 Nobel Prize in Physiology or Medicine for microRNA discovery
  • +1 more outcomes

Companies that use National Institute of General Medical Science

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles4 records

National Institute of General Medical Science technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

National Institute of General Medical Science partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

National Institute of General Medical Science competitors and assessment

Company assessment

Direct peers

  • National Cancer Institute (NCI): Fellow NIH institute with comparable statutory authority to distribute federal biomedical research grants and operate intramural programs; the closest analogue in mission structure and scale, though disease-focused on cancer rather than basic science.
  • National Heart, Lung, and Blood Institute (NHLBI): One of the largest NIH institutes, sharing NIGMS's federal-grantmaking model, peer review through CSR, and appropriations-funded budget; cited in NIGMS's FOIA correspondence, evidencing cross-institute operational ties.
  • National Institute of Allergy and Infectious Diseases (NIAID): NIH institute funding biomedical research with a comparable grants/contracts apparatus; noted as a prior employer of NIGMS's GMCDB director, illustrating the close inter-institute leadership circulation across NIH.
  • National Institute of Neurological Disorders and Stroke (NINDS): NIH institute with parallel grant programs (R01, P01, training) and shared administrative infrastructure; comparable in funding mechanisms, peer-review pathways, and congressional appropriations dynamics.
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NIH institute funding biomedical and behavioral research with overlapping training and workforce development programs; structurally and operationally comparable to NIGMS as a federal grantmaking body.
  • National Center for Advancing Translational Sciences (NCATS): NIH center focused on translational science; shares NIGMS's grant and training mechanisms and was a prior employer of an NIGMS division director, evidencing interagency personnel flow and parallel program design.

Broad incumbents

  • National Science Foundation (NSF): Largest federal basic-research funder; overlaps with NIGMS on investigator-initiated biomedical and biological sciences research, but at broader scientific scope and without NIH's disease-specific mandate.

Emerging players

  • Howard Hughes Medical Institute (HHMI): Large private biomedical research funder supporting investigator-driven basic science at host institutions; runs a comparable scientist-support model rather than open R01-style competitive grants, but competes for talent and prestige in the same research ecosystem.
  • Wellcome Trust: UK-headquartered global charitable foundation that funds basic biomedical research and research training; analogous mission to NIGMS but private/charity-funded and internationally scoped, often co-funding investigators alongside NIH.

Others

  • U.S. Department of Energy Office of Science: Federal basic-research funder operating national user facilities (e.g., synchrotron light sources) that overlap with NIGMS's Mature Synchrotron Resources program; comparable as a federally funded science agency, though focused on physical rather than life sciences.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

National Institute of General Medical Science social profiles

Digital presence

National Institute of General Medical Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Institute of General Medical Science leadership team

Management profile

Number of profiles

Profiles8 records

National Institute of General Medical Science funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Institute of General Medical Science M&A and investment

M&A and investment

M&A

Investments48 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute of General Medical Science

What does National Institute of General Medical Science do?

The National Institute of General Medical Sciences (NIGMS) is a U.S. federal research institute within the National Institutes of Health (NIH) that distributes federal appropriations as competitive research grants to support basic biomedical research. It funds principal investigators, research institutions, training programs, and capacity-building initiatives across American universities and research institutions through grant mechanisms such as R01, MIRA, IDeA, NARCH, SuRE, and SEPA.

Is National Institute of General Medical Science a public or private company?

National Institute of General Medical Science is a public company. It is classified as state government owned and is currently operating.

When was National Institute of General Medical Science founded?

National Institute of General Medical Science was founded in 1962. It employs 101 to 250 people.

Where is National Institute of General Medical Science based?

National Institute of General Medical Science is headquartered in Bethesda, United States, in the North America region.

How does National Institute of General Medical Science make money?

One revenue line is on record: federal Government Appropriations.

Who are National Institute of General Medical Science's main competitors?

Direct peers on record are National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Center for Advancing Translational Sciences (NCATS). National Science Foundation (NSF) is listed as a broad incumbent. Emerging players are Howard Hughes Medical Institute (HHMI) and Wellcome Trust. U.S. Department of Energy Office of Science is listed as an others.

Does National Institute of General Medical Science have an API?

No public API is recorded for National Institute of General Medical Science.

What industry is National Institute of General Medical Science in?

National Institute of General Medical Science's product category is Government Research Funding. Its primary akta.pro industry code is HLAJALAB, Health Research Funding Agencies (Public/Quasi-Public), with a secondary code of BPAGAKAI, Research & Science Grantmaking Foundations. Its NAICS code is 5417 and its SIC code is 8200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsEverest Biolabs Receives $2.1M GrantEverest Biolabs, a Waltham, MA-based EV isolation and analytics provider, received a $2.1M SBIR Direct-to-Phase II grant from the NIH's NIGMS. The company will use the funds to expand operations and R&D efforts. The grant supports its automated EV isolation platform.SynBioBetaPartillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction SequencingPartillion Bioscience received a $2.1 million NIH SBIR award to expand its Cell-Cell-seq workflows, which preserve defined cell pairs and capture functional outputs. The grant, its 10th SBIR, brings total non-dilutive federal funding to over $8 million, matching private investment. The company plans to scale toward datasets of up to one million cell pairs.News-MedicalUofL receives new federal funding to advance metabolic health researchThe University of Louisville received an $11.6 million, five-year Center of Biomedical Research Excellence grant from the National Institute of General Medical Sciences to launch the Nutrition and Metabolic Health Center, backed by $7.25 million in university funds. Thirty senior researchers across multiple schools will collaborate, with core facilities including data management, multi-omics and translational metabolic phenotyping.Mirage NewsUTA Research Targets Drug-resistant BacteriaResearchers at The University of Texas at Arlington secured over $4.6 million in federal grants to study antibiotic resistance mechanisms in pathogens like Listeria monocytogenes and Staphylococcus aureus. The funding from the National Institute of General Medical Sciences and the National Institute of Allergy and Infectious Diseases aims to identify new therapeutic targets for drug-resistant infections. This research addresses an urgent public health threat identified by the Centers for Disease Control and Prevention.EIN PresswireeXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug DiscoveryeXoZymes received a $2 million NIH grant to develop cannabinoid analogs, with work starting July 1, 2026. The grant brings total non-dilutive funding to $19.7 million, and the U.S. minor cannabinoids market is forecast to grow from $11.5 billion in 2023 to $33.3 billion by 2030.NewswireeXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug DiscoveryeXoZymes received a $2 million NIH grant to advance cannabinoid analogs for drug discovery. The two-year project starts July 1, 2026, and is the second biosolution in its pipeline. Total non-dilutive funding now approaches $20 million.EIN PresswireInfluential Women profiles Soukaina Amniouel, PhD, computational biology fellow advancing cancer research at NCATS.Soukaina Amniouel, PhD, is a postdoctoral fellow in computational biology at NCATS, applying bioinformatics and AI/ML to cancer, neurological, and rare disease research. She earned her PhD from George Mason University, developing machine learning models to predict chemotherapy efficacy, and serves as adjunct faculty at the same university.Lane ReportNIH awards UK $11.3M for Phase 2 chemical biology pharmaceutical researchThe University of Kentucky received an $11.3 million Phase 2 COBRE grant from the NIH for its Translational Chemical Biology center. Phase 1 secured $71.3 million in new funding and eight junior faculty transitions. The center aims to build toward a Phase 3 renewal.Worcester Business JournalUMass Chan granted $1.6M to study safer gene therapy delivery methodsA UMass Chan researcher received a $1.6-million federal grant to study safer gene therapy delivery methods. The funding, from the National Institute of General Medical Sciences, will support research on adeno-associated viral vectors to reduce potential cancer risks. The study aims to improve vector design and inform further research.SBU NewsSun Receives MIRA Award from National Institute of General Medicine SciencesAssistant professor Simou Sun received a $2.2 million Maximizing Investigators' Research Award from NIGMS for five years. The award supports her research on extracellular particle-mediated signaling at biointerfaces, aiming to inform diagnostics, therapeutics, and environmental sensing.